Virtual HDRSM CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 5, 2008, Pages 1588-1597

  Fuller, Donald B ^a   Naitoh, John ^b   Lee, Charles ^a   Hardy, Steven ^a   Jin, Haoran ^a  

^a San Diego CyberKnife Center   (United States)

^b Coast Urology Medical Group Inc ^*  (United States)

Author keywords

Brachytherapy; CyberKnife; Dosimetry; High dose rate; Image guided; Prostate cancer; Stereotactic body radiotherapy

Indexed keywords

CATHETERS; CLINICAL LABORATORIES; DOSIMETRY; DRUG DOSAGE; ONCOLOGY; RADIOTHERAPY; UROLOGY;

BRACHYTHERAPIES; CYBERKNIVES; HIGH DOSE RATES (HDR); IMAGE GUIDED; PROSTATE CANCER; STEREOTACTIC BODY RADIOTHERAPY;

TUMORS;

PROSTATE SPECIFIC ANTIGEN;

ACUTE TOXICITY; ARTICLE; BLADDER; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RECTUM; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; URETHRA; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PROSTATE; PROSTATE TUMOR; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; RADIOMETRY; RADIOSURGERY; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING;

BRACHYTHERAPY; DOSE FRACTIONATION; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOBIOLOGY; RADIOMETRY; RADIOSURGERY; RADIOTHERAPY DOSAGE; RECTUM; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; URETHRA; URINARY BLADDER;

EID: 40949091902     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.067     Document Type: Article

References (25)

1. Grills I.S., Martinez A.A., Hollander M., et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171 (2004) 1098-1104
2. Demanes D.J., Rodriguez R.R., Schour L., et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61 (2005) 1306-1316
3. 192Iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 41 (1998) 525-533
4. Vargas C.E., Martinez A.A., Boike T.P., et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a Phase I to II study. Int J Radiat Oncol Biol Phys 66 (2006) 416-423
5. McNeal J.E., Redwine E.A., Freiha F.S., et al. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12 (1988) 897-906
6. King C.R., Lehmann J., Adler J.R., et al. CyberKnife radiotherapy for localized prostate cancer: Rationale and technical feasibility. Technol Cancer Res Treat 2 (2003) 25-30
7. Williams S.G., Taylor J.M.G., Liu N., et al. Estimation of the α/β ratio of prostate cancer using a multivariate analysis of the individual fraction size data of 3756 patients. Int J Radiat Oncol Biol Phys 66 Suppl. (2006) S10-S11
8. Demanes D., Altieri G., Barnaba M., et al. High dose rate (HDR) monotherapy is equivalent to combined HDR brachytherapy and external beam radiation therapy (EBRT) for early prostate cancer. [Abstract]. Int J Radiat Oncol Biol Phys 66 Suppl. (2006) S351
9. Chang S.D., Main W., Martin D.P., et al. An analysis of the accuracy of the CyberKnife: A robotic frameless stereotactic radiosurgical system. Neurosurgery 52 (2003) 140-146 discussion, 146-147
10. Ho A.K., Fu D., Cotrutz C., et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery 60 (2007) ONS147-ONS156 discussion ONS156
11. Villers A., McNeal J.E., Freiha F.S., et al. Invasion of Denonvilliers' fascia in radical prostatectomy specimens. J Urol 149 (1993) 793-798
12. Chao K.K., Goldstein N.S., Yan D., et al. Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?. Int J Radiat Oncol Biol Phys 65 (2006) 999-1007
13. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 49 (2001) 61-69
14. Martin T., Baltas D., Kurek R., et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 180 (2004) 225-232
15. Yamada Y., Bhatia S., Zaider M., et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 5 (2006) 157-164
16. Akimoto T., Katoh H., Kitamoto Y., et al. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of Grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys 65 (2006) 364-370
17. Lotan Y., Stanfield J., Cho L.C., et al. Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model. J Urol 175 (2006) 1932-1936
18. Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1088-1098
19. Bastin K.T., Podgorsak M.B., and Thomadsen B.R. The transit dose component of high dose rate brachytherapy: Direct measurements and clinical implications. Int J Radiat Oncol Biol Phys 26 (1993) 695-702
20. Kiffer J.D., Schumer W.A., Mantle C.A., et al. Impact of oedema on implant geometry and dosimetry for temporary high dose rate brachytherapy of the prostate. Australas Radiol 47 (2003) 172-176
21. Hoskin P.J., Bownes P.J., Ostler P., et al. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions. Radiother Oncol 68 (2003) 285-288
22. Hara W., Patel D., Pawlicki T., et al. Hypofractionated stereotactic radiotherapy for prostate cancer: Early results. Int J Radiat Oncol Biol Phys 66 Suppl. (2006) S324-S325
23. Zagars G.K., and Pollack A. The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: An early indicator of response to treatment. Radiother Oncol 30 (1994) 121-127
24. Blasko J.C., Grimm P.D., Sylvester J.E., et al. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46 (2000) 839-850
25. Wei J.T., Dunn R.L., Litwin M.S., et al. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56 (2000) 899-905